These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17066899)

  • 21. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
    Ribeiro RM; Hazenberg MD; Perelson AS; Davenport MP
    J Virol; 2006 Jan; 80(2):802-9. PubMed ID: 16378982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC; Margolis LB
    Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD4 controls the susceptibility of THP-1 cells to infection by R5 and X4 HIV type 1 isolates.
    Konopka K; Düzgüneş N
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):123-31. PubMed ID: 11839145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X4-tropic human immunodeficiency virus IIIB utilizes CXCR4 as coreceptor, as distinct from R5X4-tropic viruses.
    Islam S; Hoque SA; Adnan N; Tanaka A; Jinno-Oue A; Hoshino H
    Microbiol Immunol; 2013 Jun; 57(6):437-44. PubMed ID: 23773022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.
    Symons J; van Lelyveld SF; Hoepelman AI; van Ham PM; de Jong D; Wensing AM; Nijhuis M
    J Antimicrob Chemother; 2011 Apr; 66(4):890-5. PubMed ID: 21393136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines.
    Mariani SA; Brigida I; Kajaste-Rudnitski A; Ghezzi S; Rocchi A; Plebani A; Vicenzi E; Aiuti A; Poli G
    Blood; 2012 Mar; 119(9):2013-23. PubMed ID: 22234680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5).
    Hachiya A; Aizawa-Matsuoka S; Tanaka M; Takahashi Y; Ida S; Gatanaga H; Hirabayashi Y; Kojima A; Tatsumi M; Oka S
    Antimicrob Agents Chemother; 2001 Feb; 45(2):495-501. PubMed ID: 11158746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.
    Zhao Q; Lu H; Schols D; De Clercq E; Jiang S
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):947-55. PubMed ID: 14678601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection.
    Schmitt N; Nugeyre MT; Scott-Algara D; Cumont MC; Barré-Sinoussi F; Pancino G; Israël N
    AIDS; 2006 Feb; 20(4):533-42. PubMed ID: 16470117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.
    Harada T; Tatsumi M; Takahashi H; Sata T; Kurata T; Kojima A
    Microbes Infect; 2004 Apr; 6(5):421-8. PubMed ID: 15109956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4.
    Owen A; Chandler B; Bray PG; Ward SA; Hart CA; Back DJ; Khoo SH
    J Virol; 2004 Nov; 78(21):12022-9. PubMed ID: 15479841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
    Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF
    J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HIV-1 co-receptor usage of patients experienced anti-retroviral therapy].
    Qu SL; Yuan L; Huang Y; Xu WS; Yu XL; Liu YL; Xing H; Shao YM; Ma LY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):985-8. PubMed ID: 21215124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134.
    Kanbara K; Sato S; Tanuma J; Tamamura H; Gotoh K; Yoshimori M; Kanamoto T; Kitano M; Fujii N; Nakashima H
    AIDS Res Hum Retroviruses; 2001 May; 17(7):615-22. PubMed ID: 11375057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.
    Lee B; Sharron M; Montaner LJ; Weissman D; Doms RW
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5215-20. PubMed ID: 10220446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
    Wolinsky SM; Veazey RS; Kunstman KJ; Klasse PJ; Dufour J; Marozsan AJ; Springer MS; Moore JP
    Virology; 2004 Oct; 328(1):19-29. PubMed ID: 15380354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.